GO-QOL — disease-specific quality of life questionnaire in Graves’ orbitopathy

Nadia Sawicka-Gutaj; Tomasz Bednarczuk; Jacek Daroszewski; Joanna Waligórska-Stachura; Piotr Miśkiewicz; Jerzy Sowiński; Marek Bolanowski; Marek Ruchała

doi:10.5603/EP.2015.0046

Vol 66, No 4 (2015)

Review paper

Submitted: 2015-01-25

Accepted: 2015-02-16

Published online: 2015-09-01

View PDF

Download PDF file

View HTML

Get Citation

GO-QOL — disease-specific quality of life questionnaire in Graves’ orbitopathy

Nadia Sawicka-Gutaj, Tomasz Bednarczuk, Jacek Daroszewski, Joanna Waligórska-Stachura, Piotr Miśkiewicz, Jerzy Sowiński, Marek Bolanowski, Marek Ruchała

DOI: 10.5603/EP.2015.0046

Pubmed: 26323474

Endokrynol Pol 2015;66(4):362-366.

Vol 66, No 4 (2015)

Reviews — Postgraduate Education

Submitted: 2015-01-25

Accepted: 2015-02-16

Published online: 2015-09-01

Abstract

The main goal of therapy for Graves’ orbitopathy (GO) is to restore visual function and to improve quality of life (QOL); therefore, the idea of self-assessment of eye changes by the patient has been developed. We developed a validated Polish version of the GO-QOL questionnaire (GO-QOLpl). As an original version we used the English version of GO-QOL, which consists of 15 questions summarised in two subscales. GO-QOLpl was translated and validated in accordance with standard principles for translation of patient-reported outcomes (PRO). GO-QOLpl is a linguistically validated version of the original GO-QOL questionnaire, which is recommended by the European Group of Graves’ Orbitopathy (EUGOGO). We strongly support the use of GO-QOLpl for the assessment of QOL among Polish patients with GO in clinical practice. (Endokrynol Pol 2015; 66 (4): 362–366)